Reprogramming of non-genomic estrogen signaling by the stemness factor SOX2 enhances the tumor-initiating capacity of breast cancer cells

Vazquez-Martin, Alejandro; Cufí, Sílvia; Lopez-Bonet, Eugeni; Corominas-Faja, Bruna; Cuyàs, Elisabet; Vellon, Luciano; Iglesias, Juan Manuel; Leis, Olatz; Martín, Ángel G.; Menendez, Javier A.
November 2013
Cell Cycle;11/15/2013, Vol. 12 Issue 22, p3471
Academic Journal
No abstract available.


Related Articles

  • Effects of estrogen on the proportion of stem cells in the breast. Sim�es, Bruno; Piva, Marco; Iriondo, Oihana; Comaills, Valentine; L�pez-Ruiz, Jose; Zabalza, I�aki; Mieza, Jon; Acinas, Olga; Vivanco, Maria // Breast Cancer Research & Treatment;Aug2011, Vol. 129 Issue 1, p23 

    There is increasing evidence that breast cancers contain tumor-initiating cells with stem cell properties. The importance of estrogen in the development of the mammary gland and in breast cancer is well known, but the influence of estrogen on the stem cell population has not been assessed. We...

  • Fibroblasts induce expression of FGF4 in ovarian cancer stem-like cells/cancer-initiating cells and upregulate their tumor initiation capacity. Yasuda, Kazuyo; Torigoe, Toshihiko; Mariya, Tasuku; Asano, Takuya; Kuroda, Takafumi; Matsuzaki, Junichi; Ikeda, Kanae; Yamauchi, Makoto; Emori, Makoto; Asanuma, Hiroko; Hasegawa, Tadashi; Saito, Tsuyoshi; Hirohashi, Yoshihiko; Sato, Noriyuki // Laboratory Investigation (00236837);Dec2014, Vol. 94 Issue 12, p1355 

    Cancer stem-like cells (CSCs)/cancer-initiating cells (CICs) are defined as a small population of cells within cancer that contribute to cancer initiation and progression. Cancer-associated fibroblasts (CAFs) are stromal fibroblasts surrounding tumor cells, and they have important roles in tumor...

  • Downregulation of miR-140 promotes cancer stem cell formation in basal-like early stage breast cancer. Li, Q; Yao, Y; Eades, G; Liu, Z; Zhang, Y; Zhou, Q // Oncogene;5/15/2014, Vol. 33 Issue 20, p2589 

    The major goal of breast cancer prevention is to reduce the incidence of ductal carcinoma in situ (DCIS), an early stage of breast cancer. However, the biology behind DCIS formation is not well understood. It is suspected that cancer stem cells (CSCs) are already programmed in pre-malignant DCIS...

  • SOX2 regulates self-renewal and tumorigenicity of human melanoma-initiating cells. Santini, R.; Pandolfi, S.; Pietrobono, S.; Montagnani, V.; D'Amico, M.; Penachioni, J. Y.; Vinci, M. C.; Borgognoni, L.; Stecca, B. // Oncogene;9/18/2014, Vol. 33 Issue 38, p4697 

    Melanoma is one of the most aggressive types of human cancer, characterized by enhanced heterogeneity and resistance to conventional therapy at advanced stages. We and others have previously shown that HEDGEHOG-GLI (HH-GLI) signaling is required for melanoma growth and for survival and expansion...

  • Progestin suppression of miR-29 potentiates dedifferentiation of breast cancer cells via KLF4. Cittelly, D M; Finlay-Schultz, J; Howe, E N; Spoelstra, N S; Axlund, S D; Hendricks, P; Jacobsen, B M; Sartorius, C A; Richer, J K // Oncogene;5/16/2013, Vol. 32 Issue 20, p2555 

    The female hormone progesterone (P4) promotes the expansion of stem-like cancer cells in estrogen receptor (ER)- and progesterone receptor (PR)-positive breast tumors. The expanded tumor cells lose expression of ER and PR, express the tumor-initiating marker CD44, the progenitor marker...

  • A positive feedback loop of ER-α36/EGFR promotes malignant growth of ER-negative breast cancer cells. Zhang, X T; Kang, L G; Ding, L; Vranic, S; Gatalica, Z; Wang, Z-Y // Oncogene;2/17/2011, Vol. 30 Issue 7, p770 

    It is prevailingly thought that estrogen signaling is not involved in development of estrogen receptor (ER)-negative breast cancer. However, there is evidence indicating that ovariectomy prevents the development of both ER-positive and -negative breast cancer, suggesting that estrogen signaling...

  • Emerging Role of Long Non-Coding RNA SOX2OT in SOX2 Regulation in Breast Cancer. Askarian-Amiri, Marjan E.; Seyfoddin, Vahid; Smart, Chanel E.; Wang, Jingli; Kim, Ji Eun; Hansji, Herah; Baguley, Bruce C.; Finlay, Graeme J.; Leung, Euphemia Y. // PLoS ONE;Jul2014, Vol. 9 Issue 7, p1 

    The transcription factor SOX2 is essential for maintaining pluripotency in a variety of stem cells. It has important functions during embryonic development, is involved in cancer stem cell maintenance, and is often deregulated in cancer. The mechanism of SOX2 regulation has yet to be clarified,...

  • Response of Estrogen Receptor-Positive Breast Cancer Tumorspheres to Antiestrogen Treatments. Ao, Ada; Morrison, Brian J.; Heiman Wang; López, J. Alejandro; Reynolds, Brent A.; Jianrong Lu // PLoS ONE;2011, Vol. 6 Issue 4, p1 

    Estrogen signaling plays a critical role in the pathogenesis of breast cancer. Because the majority of breast carcinomas express the estrogen receptor ERα, endocrine thERαpy that impedes estrogen-ER signaling reduces breast cancer mortality and has become a mainstay of breast cancer...

  • Sox2 maintains self renewal of tumor-initiating cells in osteosarcomas. Basu-Roy, U; Seo, E; Ramanathapuram, L; Rapp, T B; Perry, J A; Orkin, S H; Mansukhani, A; Basilico, C // Oncogene;5/3/2012, Vol. 31 Issue 18, p2270 

    Tumors are thought to be sustained by a reservoir of self-renewing cells, termed tumor-initiating cells or cancer stem cells. Osteosarcomas are high-grade sarcomas derived from osteoblast progenitor cells and are the most common pediatric bone malignancy. In this report we show that the stem...

  • Functional Heterogeneity within the CD44 High Human Breast Cancer Stem Cell-Like Compartment Reveals a Gene Signature Predictive of Distant Metastasis. Terp, Mikkel G.; Petersen, Ole W.; Leth-Larsen, Rikke; Kühlwein, Thorsten; Jensen, Ole N.; Elias, Daniel; Ditzel, Henrik J.; Christensen, Anne G. // Molecular Medicine;Jul2012, Vol. 18 Issue 7, p1109 

    The CD44hi compartment in human breast cancer is enriched in tumor-initiating cells; however, the functional heterogeneity within this subpopulation remains poorly defined. We used a triple-negative breast cancer cell line with a known bilineage phenotype to isolate and clone CD44hi single cells...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics